Company profilestartontx.com ↗

Starton Therapeutics

Starton Therapeutics is a Phase 2 clinical-stage biotechnology platform company.

Biotechnology Research
Headquarters
Paramus, New Jersey, United StatesSource: RevenueBaseRetrieved October 13, 2026
Employee range
11 to 50Source: RevenueBaseRetrieved October 13, 2026
Founded
2017Source: RevenueBaseRetrieved October 13, 2026
Published list appearances
7 supported appearances ↗Source: RevenueBase lists
The company at a glance

What does Starton Therapeutics do?

The company’s initial focus is treating hematologic malignancies with STAR-LLD, a controlled low-dose formulation of lenalidomide. The company is investigating STAR-LLD in combination with T-cell engager and CAR-T cell therapies for lymphoma and multiple myeloma.

Based on the company’s public LinkedIn information, supplied through RevenueBase.

What the business offers

Services & capabilities.

Therapy delivery technology

The company uses proprietary delivery technology to transform therapies.

Source: LinkedIn company description · Retrieved October 13, 2026

Lenalidomide formulation

STAR-LLD is the company’s lead candidate, a controlled low-dose formulation of lenalidomide.

Source: LinkedIn company description · Retrieved October 13, 2026

Explore the business in context

Company lists.

Supported appearances on published RevenueBase lists, including available memberships beyond displayed rankings.

Positions describe ordering within each source list. See how lists are built ↗

Share your recognition

Embeddable award for your website

BADGE PREVIEWStarton Therapeutics listed #13 on Transdermal delivery system companies, September 21, 2026Open the published source list.
Starton Therapeutics

#13 Transdermal delivery system companies

Snapshot: September 21, 2026

Download SVG
View live list ↗

Company information

Sources & data notes.

RevenueBase prepared this profile from the company’s public LinkedIn information and RevenueBase company data. These source records were retrieved on October 13, 2026. AI helped summarize these sources, with a separate automated check against the source text completed on November 4, 2026. Directory positions use company-contact counts from separate saved list snapshots dated September 16, 2026, September 18, 2026, September 19, 2026 and September 21, 2026. How the company lists are built.

Help keep this profile accurate

Something changed?

Share a correction, your relationship to the company, and supporting sources. Requests are reviewed before changes are published.

Find your next account

One company is just the start.

Explore more companies by name, headquarters and business focus.

Explore company profiles →